A new study published online in the American Journal of Respiratory and Critical Care Medicine reveals that comorbidities amongst patients with chronic obstructive pulmonary disease (COPD) are common, and that several of these comorbidities are indepen…
New research from Austria suggests that a protein called HSP27 has the potential to be a new blood biomarker for the earlier detection of chronic obstructive pulmonary disease (COPD), thereby increasing the chance of earlier treatment and better outc…
According to a study published online ahead of print publication in the American Thoracic Society’s American Journal of Respiratory and Critical Care Medicine, adding inflammatory biomarkers to established clinical variables significantly improves the …
In the first comprehensive review of its kind since 1992, a UC Davis researcher has estimated the national annual price tag of occupational injuries and illnesses at $250 billion, much higher than generally assumed. That figure is $31 billion more than…
The European Federation of Allergy and Airways Diseases Patients’ Associations (EFA) launched its policy recommendation on World COPD Day to reduce the 32.8 billion EUR that are currently spent every year for COPD, and to improve the lives of ca. 44 mi…
According to a study in the October 26 issue of JAMA researchers found that CT (computer tomographic) scans utilized for lung cancer screening showed that a significant proportion of current or former male smokers had chronic obstructive pulmonary dise…
A new study has found that processes that control heart rate play an important role in the quality of life experienced by patients with chronic obstructive pulmonary disease (COPD). The study, which was published in the journal Respirology, indicates t…
A new study published in the journal Respirology suggests that heart-related therapies could potentially improve the wellbeing of some people suffering from chronic obstructive pulmonary disease (COPD) as the mechanisms controlling the heart play a vit…
A new study presented at the European Respiratory Society’s Annual Congress in Amsterdam, shows that underweight chronic obstructive pulmonary disease (COPD) patients have a higher risk of mortality risk. According to predictions made by The World H…
At the European Respiratory Society (ERS) congress in Amsterdam, Novartis presented new Phase III data and demonstrated the potential of their new once-daily inhaled treatments for individuals suffering with COPD, which helps patients to maintain more …
